Gemtuzumab ozogamicin (Mylotarg®) in children with refractory or relapsed acute myeloid leukemia

D. Reinhardt, S. Diekamp, G. Fleischhack, S. Corbacioglu, H. Jürgens, M. Dworzak, G. Kaspers, U. Creutzig, C. M. Zwaan

Research output: Contribution to journalArticlepeer-review

41 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Gemtuzumab ozogamicin (Mylotarg®) in children with refractory or relapsed acute myeloid leukemia'. Together they form a unique fingerprint.

Medicine & Life Sciences